Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism
Yaojie Fu(National Institutes of Health), Hong Shen(Central South University), Zhanwei Zhu(Central South University), Dechun Feng, Bryan Mackowiak(National Institutes of Health), Ying Han(Xijing Hospital), Cao Guo(Central South University), Shan Zeng(Fudan University), Shanshan Liu(Central South University), Bin Gao(National Institutes of Health), Yong He, Robim M. Rodrigues(National Institute on Alcohol Abuse and Alcoholism)
Cited by 32
Related Papers
Hepatocytes: a key cell type for innate immunity
|Cellular and Molecular Immunology|2015|449
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
|Hepatology|2012|438
Patient-derived xenograft models in cancer therapy: technologies and applications
|Signal Transduction and Targeted Therapy|2023|419
Alcohol-associated liver disease
|Journal of Clinical Investigation|2024|304